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ABSTRACT The self-assembly and aggregation of insulin molecules has been investigated by means of nanoflow electro-
spray mass spectrometry. Hexamers of insulin containing predominantly two, but up to four, Zn2 ions were observed in the
gas phase when solutions at pH 4.0 were examined. At pH 3.3, in the absence of Zn2, dimers and tetramers are observed.
Spectra obtained from solutions of insulin at millimolar concentrations at pH 2.0, conditions under which insulin is known to
aggregate in solution, showed signals from a range of higher oligomers. Clusters containing up to 12 molecules could be
detected in the gas phase. Hydrogen exchange measurements show that in solution these higher oligomers are in rapid
equilibrium with monomeric insulin. At elevated temperatures, under conditions where insulin rapidly forms amyloid fibrils, the
concentration of soluble higher oligomers was found to decrease with time yielding insoluble high molecular weight
aggregates and then fibrils. The fibrils formed were examined by electron microscopy and the results show that the
amorphous aggregates formed initially are converted to twisted, unbranched fibrils containing several protofilaments. Fourier
transform infrared spectroscopy shows that both the soluble form of insulin and the initial aggregates are predominantly
helical, but that formation of -sheet structure occurs simultaneously with the appearance of well-defined fibrils.
INTRODUCTION
Mass spectrometry (MS) is undergoing a period of unprec-
edented growth in its applications. This is due largely to its
wide spread use in sequencing for proteomic applications
(Kuster and Mann, 1998), but also to the growing number of
examples of non-covalent interactions that have been main-
tained in the gas phase (Rostom and Robinson, 1999). The
growth in both these applications derives largely from tech-
nological advances, particularly the introduction of nano-
flow electrospray techniques (Wilm and Mann, 1994). This
methodology has lead to an enhanced sensitivity, important
for proteomic applications, and facilitated the analysis of
aqueous solutions containing metal ions and buffers (Vis et
al., 1998); this is critical for the study of non-covalent
interactions. In addition the recent combination of nanoflow
electrospray with time-of-flight analysis offers the promise
of an unlimited mass-to-charge range, a property that is only
beginning to be realized and which has enabled the analysis
of intact ribosomes (Rostom et al., 2000) and viruses (Tito
et al., 2000). These observations of multi-protein complexes
suggest that it may now be possible to apply mass spec-
trometry to study large, weakly associated protein aggre-
gates in solution. The process of aggregation is notoriously
difficult to study directly by conventional techniques but is
becoming increasingly important for example as it is widely
accepted to be involved in the early stages of amyloid fibril
formation (Harper and Lansbury, 1997). Insulin provides an
ideal system for testing this hypothesis since it forms well-
defined oligomers in its native state yet can be induced to
aggregate and form amyloid fibrils under non-physiological
conditions. Consequently insulin can form both specific and
nonspecific oligomeric states, providing an excellent model
system for distinguishing such associations by mass spec-
trometry. Moreover understanding the aggregation process
is important, not only in this case from the point of view of
the long-term storage and pharmaceutical use of insulin, but
also for the possible insight it may provide into the mech-
anism of protein aggregation and fibril formation more
generally.
The protein hormone insulin is synthesized in the  cells
of the pancreas where it is stored as a Zn2-containing
hexamer. X-ray analysis of the two Zn2 hexamers of
porcine insulin shows that each monomer unit is essentially
helical and contains 51 amino acids in two chains (an acidic
A chain of 21 residues and a basic B chain of 30 residues),
cross-linked by two disulfide bridges (Adams et al., 1969).
A third disulfide bridge links two parts of the A chain. The
two-Zn2 hexamer is composed of three equivalent dimers,
each coordinated by the side chains of B10 His. In the
treatment of type I diabetes the Zn2-containing hexamer of
insulin is injected into the musculature. Its large size, how-
ever, prevents its efficient absorption into the blood stream.
Hexamers are therefore broken down to dimers and then
monomers that are then transported efficiently into the
blood stream (Brange et al., 1997c). Both the monomeric
and dimeric forms of insulin are prone to aggregation, a
property that has severely limited the use of insulin in
pharmaceutical preparations. The formation of aggregation-
prone species is avoided during storage and injection of
insulin by the use of the more stable two-Zn2 hexamer
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(Brange et al., 1997c) or by the use of analogs of insulin that
are stable in monomeric form (Brange and Volund, 1999).
In addition to forming well-defined assemblies under
native conditions insulin has been found to form amyloid
fibrils in vitro (Langmuir and Waugh, 1940). The turbidity
of solutions was used to indicate the extent of the aggrega-
tion process and was shown to be more rapid at high
temperatures (60–70°C), at low pH (1.5–2.0) and at rela-
tively high protein concentrations (mM) (Brange et al.,
1997a). Early x-ray diffraction patterns of in vitro insulin
fibrils formed under these conditions were interpreted as
showing an essentially linear aggregate of slightly modified
native insulin (Koltun et al., 1954). Later studies, however,
using x-ray diffraction in combination with optical spectros-
copy proposed that substantial changes in conformation
accompany the formation of cross--fibrils from native
insulin (Burke and Rougvie, 1972b). In vitro studies have
shown that removal of residues at the C-terminus of the B
chain, to give the des-pentapeptide and des-octapeptide
species, leads to an increased rate of aggregation while
linking the C-terminus of the B chain to the N-terminus of
the A chain leads to a greatly reduced tendency to form
aggregates (Brange et al., 1997a). These findings have been
interpreted to imply that the C-terminus plays a major role
in the process of fibril formation. A model based on the
crystal structure of despentapepetide insulin was used to
suggest that insulin enters the fibril with little perturbation
from the helical structure of the native state (Brange et al.,
1997b). Infrared spectroscopy, however, indicates that sig-
nificant conversion of -helical to -sheet structure accom-
panies formation of amyloid fibrils (Burke and Rougvie,
1972a; Bouchard et al., submitted).
In this paper we describe the use of a nanoflow electro-
spray (nano-ES) mass spectrometric approach to probe the
nature of the species present in solution when bovine insulin
undergoes self-assembly, aggregation and amyloid fibril
formation. Using carefully controlled nano-ES mass spec-
trometry conditions we have monitored the formation of
soluble oligomers of the insulin molecule in its native
conformation. Under conditions that promote more exten-
sive aggregation we have probed the association of oli-
gomers using time-of-flight mass analysis. Using hydrogen
exchange methods, we have examined the equilibrium be-
tween monomeric and oligomeric forms of the protein.
Under the same solution conditions, but at elevated temper-
atures, the conversion of these soluble oligomers to amyloid
fibrils appears more rapid and the presence of the various
oligomers is explored as a function of time. To verify that
fibrils form during these experiments the solutions were
examined by electron microscopy, x-ray diffraction and
Fourier transform infrared spectroscopy (FT-IR). Combina-
tion of the mass spectrometry data together with the FT-IR
suggests an outline of the structural transitions involved
in the formation of amyloid fibrils from soluble insulin
molecules.
MATERIALS AND METHODS
Materials
Bovine and human insulins were purchased from Sigma Chemical Com-
pany (Poole, Dorset, UK). MilliQ water (Millipore Ltd., Bedford, MA) was
used in all experiments and the pH of buffers was adjusted using HCl
(Fisons Scientific, Loughborough, UK) or ammonia (BDH, Poole, UK).
Zinc phosphate was purchased from Sigma Chemical Company (Poole,
Dorset, UK). The concentration of protein solutions was determined by the
Bicinchoninic acid assay (Pierce Chemical Company, Rockford, IL). D2O
and DCl were purchased from Aldrich Chemical Co, Poole, Dorset, and
Fluka, Buchs, Switzerland, respectively.
Mass spectrometry
All mass spectra were recorded on Platform II and Q-tof mass spectrom-
eters (Micromass UK Ltd.) without source heating and in the absence of
organic co-solvents. 2 l of protein solution were introduced via a nano-
flow electrospray interface from a gold-plated borosilicate needle with
approximately 1 m internal diameter at 20°C. Needles were prepared in
house from borosilicate glass capillaries (Clarke Electromedical Instru-
ments, Reading, UK) of external diameter 1.0 mm and internal diameter
0.5 mm on a model P-97 Flaming/Brown micropipette puller (Sutter
Instrument Company, Sittingbourne, UK), and gold coated with a Polaron
SEM coating system (Applied Vacuum Engineers, Bristol, UK). Mass
spectrometer conditions were set with a capillary voltage of 1.3 kV and a
skimmer offset of 5 V and a source pressure of 5  105 mBar with the
use of a collision gas in the Q-tof mass spectrometer to achieve this
pressure. Each spectrum was obtained from a new aliquot of the protein
solution and a new nanoflow needle was used for each acquisition. Anal-
ysis of the mass spectra was performed with MassLynx 3.1, (Micromass
UK Ltd.). The average masses of protein samples were calculated from the
charge states shown. All spectra were calibrated using hen lysozyme
(Sigma Chemical Co., Poole, Dorset, UK) in H2O at pH 5.0. The masses
measured are centroid values, which take into account the asymmetry of
the peaks arising from the natural isotope distribution. The estimated error
in these measurements is calculated from the standard deviation of the
charge states. All mass spectra are presented as raw data, on a m/z scale,
with minimal smoothing and without any resolution enhancement. The data
were acquired in triplicate to confirm the reproducibility of the results.
Desalted samples were prepared by washing extensively on Centricon 3
concentrators (Amicon, Stonehouse, Gloucestershire, UK) with H2O at pH
2.0 to give a stock solution with a concentration of approximately 30
mg/ml. Insulin samples at pH 2.0 and at various protein concentrations
were prepared by dilution of the stock solution into a HCl buffer at pH 2.0.
Samples at pH 3.3 and pH 4.0 were prepared by further dialysis of the stock
solution using Centricon 3 concentrators with an HCl buffer at the appro-
priate pH. Samples at pH 4.0, containing excess Zn2 as the only metal ion
present, were prepared by further washing of the pH 2.0 protein stock
solutions with a HCl buffer at pH 4.0 containing 10 mM zinc phosphate.
The concentration of soluble bovine protein during the aggregation process
was measured using an equimolar quantity human insulin as an internal
standard. An aliquot of the human protein (5 l) was added immediately
prior to recording the spectrum to a 5 l aliquot of the pH 2.0 solution
incubated at 70°C for various times. This allows the relative intensities of
the two protein signals to be recorded in the same spectrum and provides
a measure of the concentration of the soluble bovine protein.
FT-IR
For FT-IR analyses insulin was dissolved in D2O and the solution was
adjusted to pH* (glass electrode pH reading in D2O solution) 2.0 with DCl
(Fluka, Buchs, Switzerland). Deuterated-protein samples were prepared by
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dissolving protein in 10 ml of the D2O buffer to give a solution of 10
mg/ml. After 24 h the sample was lyophilized and this procedure was
repeated until mass spectrometry analysis showed that all exchange-labile
protons in the protein had exchanged with deuterons. The mass spectrum
of this sample gave a mass of 5818 Da consistent with 98% deuterium
incorporation. Infrared spectra of protein samples mounted between two
NaCl plates were collected on a FT-IR spectrometer (BioRad). Soluble
deuterated-protein samples were analyzed at 20 mg/ml in D2O at pH*
2.0, while fibril samples were analyzed as a suspension in the same buffer.
Electron microscopy
Fibril formation was followed for both deuterated and non-deuterated
protein solution in D2O and H2O at 0.2 mM protein concentration, pH* 2.0
(with HCl). This solution was incubated at 70°C for between 3 and 48 h.
Samples for electron microscopy were prepared for analysis on Formvar-
coated grids negatively stained with 2% (wt/vol) uranyl acetate in water,
washed, air dried, and then analyzed in a JEOL JEM1010 transmission
electron microscope operating at an accelerating voltage of 80 kV.
RESULTS
Mass spectrometry of specific
assemblies of insulin
Insulin solutions at 2 mM protein concentration and pH 4.0
in the presence of excess Zn2 and Cl ions were analyzed
by nano-ES MS. The spectra show a series of peaks corre-
sponding to different charge states of the protein. These
states arise from the electrospray process, and the number of
charges is related to the number of accessible basic sites on
the protein molecules (Mirza and Chait, 1994). The pre-
dominant charge states (approximately 90% of the total ion
intensity) lie between m/z 2800 and 4000 (Fig. 1). These are
assigned to 9, 10, and 11 and correspond to a molec-
ular mass of 34.528 7 Da, a value in close agreement with
that calculated (35532 Da) for a hexamer of insulin with two
Zn2 ions bound (Table 1). In addition, charge states of
monomeric (8%) and dimeric species (1%) can also be
detected in the spectra. The proportions of the oligomers,
calculated from the area under the peaks enables the value
of the association constant (KA) of dimer to hexamer to be
calculated as 1.49  0.2 1010 M at pH 4.0. This value is
in reasonable agreement with a value determined from
solution measurements under somewhat different conditions
(4.0  108 M) (Goldman and Carpenter, 1974). Both meth-
ods reflect the highly favorable association constant for the
formation of the hexamer in the presence of Zn2.
Closer examination of individual charge states of the
hexameric complex indicates that they consist of not one but
a number of well-defined peaks (Fig. 1). The masses mea-
sured from these peaks identify them as arising from insulin
hexamers differing in the number of bound Zn2 ions
(Table 1). The most abundant hexameric species observed
by MS has two bound Zn2 ions but there are also intense
peaks corresponding to hexamer assemblies containing
three and four Zn2 ions. Previous mass spectrometry mea-
surements established that Zn2 bound hexamers could be
maintained in the gas phase from analysis of a solution at
pH 8.0 and the heterogeneity observed in the spectrum was
attributed to the binding of water molecules (Fabris and
Fenneslau, 1999). Analysis of x-ray structures has shown
hexamer assemblies with two further sites for Zn2 binding
in addition to the two major sites (Schlichtkrull, 1958).
More recent x-ray studies have shown that even in the
presence of excess Zn2, these two additional sites are not
completely occupied in the crystal (Smith et al., 1984),
resulting in partial occupancy of four Zn2 sites and giving
a Zn2 content on average between two and three Zn2 ions
FIGURE 1 Nano-ES mass spectrum
of insulin at pH 4.0 in the presence of
Zn2 and Cl ions showing that the
dominant charge states (11 and10)
correspond in mass to the hexamer with
a small proportion of monomer and
dimer present, The number of insulin
molecules in the oligomer is indicated
and the charge state is shown in paren-
theses. Inset: Expansion of the 11
charge state of the hexamer showing
that the major species contains two
bound Zn2 ions but species containing
up to four Zn2 ions are observed.
There is an additional low intensity
species at m/z 2458 (labeled *), which
corresponds in mass to a two-Zn2
hexamer in which one insulin molecule
contains a C-terminal alanine trunca-
tion. Although this impurity is present
in monomeric forms of insulin (1–
2%), in the hexamer the probability of
one of the six insulin molecules con-
taining this truncation is increased.
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per hexamer. Hexameric species with more than four, or
less than two, Zn2 ions bound were not detected indicating
that the binding of zinc in this assembly is specific. Con-
sequently the number of Zn2 ions in hexamers observed by
MS agrees very well with the occupancy anticipated from
crystallographic experiments.
Concentration-dependent association of insulin has been
observed in solution in the absence of Zn2 (Jeffrey and
Coates, 1966; Lord et al., 1973; Pocker and Biswas, 1981).
This is also evident in mass spectra of insulin obtained from
solutions at pH 3.3 over the concentration range 2 M to 5
mM (Fig. 2). At a protein concentration of 2 M, charge
states of 4 and 5 are observed at high intensity and their
masses confirm that they arise from monomeric insulin
(Table 1). Increasing the concentration of insulin to 10 M
gives rise to an additional peak, just visible in the spectrum
of the protein at a concentration of 2 M. This peak can be
assigned to the 7 charge state of the insulin dimer. Since
the even numbered charge states of the dimer will occur at
the same m/z values as those of the monomer, observation of
an odd numbered charge state, such as 7, is necessary to
identify the presence of dimeric insulin in the gas phase
(Table 1). It is interesting to note that at pH 3.3, where the
majority of side chains are positively charged, the dominant
charge states for the monomer and dimer are 5 and 7,
respectively. This reduction from 10 to 7 charges for a pair
of molecular ions when forming a dimer suggests that at, on
average, three ionic interactions not present in the mono-
meric species are involved in the stabilization of the dimer
structure.
As the concentration of the insulin solution is increased
from 10 M to 200 M there is a large increase in the
intensity of the 7 charge state, an observation consistent
with increased dimer formation at higher protein concentra-
tions. At insulin concentrations of 1 mM and 5 mM, addi-
tional peaks in the range m/z 2000–2900 are evident. These
arise predominantly from the charge states of a single ad-
ditional species, a tetramer (Table 1). For the reasons out-
lined above, the 9 charge state provides a unique assign-
ment for the tetramer. Measurement of the relative
proportions of the species detected at the different protein
concentrations enables the estimation of association con-
stants. A plot of the fractional intensity of the peaks as-
signed to dimeric species present in mass spectra against the
concentration of insulin measured over the range from 2
M to 200 M, enables K12 to be determined as 1.0  10
4
M (Fig. 2 B). This value is similar to reported values of
0.75  104 M, measured at pH 3.5 and 26°C, and 1.09 
104 M, measured at pH 2.0 and 15°C for K12 (Lord et al.,
1973). For the solution conditions used here, pH 3.3 and
22°C, K24 was found to be 7.7 1.8 10
1 M. The reported
values of K24 at pH 7.0 and pH 2.0 are 5 10
3 M and 7.8
102 M, respectively (Pocker and Biswas, 1981; Jeffrey and
Coates, 1966). The value determined by MS for K24 is lower
than those reported for solution based measurements at pH
2.0 and 7.0. This may arise from the different solution
conditions employed for the measurements. Nevertheless all
three measurements indicate that dimer to tetramer associ-
ation is very weak and is therefore likely to be prone to
error. The value determined by MS for K12, however, is
more favorable and is very similar to that determined from
solution based methods.
Mass spectrometry of insulin under
aggregation conditions
The spectrum of a 2 mM solution of insulin at pH 2.0 is
highly complex with multiple series of charge states in the
m/z range 3800–5000 (Fig. 3). The latter can be assigned to
assemblies containing up to 12 molecules of insulin. The
analysis of these data is, however, complicated since several
oligomers give rise to overlapping charge states. In order to
overcome this problem, the charge states of all oligomers
from a tetramer to a 12-mer were simulated. Using this
procedure the9 and11 charge states of the 7-mer can be
assigned uniquely (Fig. 3 and Table 1), since no other
oligomers are predicted to give rise to significant intensity
at these m/z values (4460 and 3649, respectively). The peak
at m/z 4300, by contrast, could arise from three different
species, a hexamer (8), a 9-mer (12), or a 12-mer (16).
Since the electrospray process produces a distribution of
charges on the oligomeric species, giving rise to a charge
state distribution that rarely contains less than three charge
states with significant intensity, the absence of detectable
signals from neighboring charge states can be used to dis-
tinguish these possibilities. For example, the 9-mer charge
states (11) and (13) have unique assignments at m/z
TABLE 1 Calculated and measured masses for insulin in the
presence and absence of Zn2 and in the oligomeric forms
observed at pH 3.2 and pH 2.0
Species No. of Zn2
Charge
states
Calculated mass
(Da)
Measured mass
(Da)
Monomer 0 3 to 6 5,734 5,733 1
Dimer 0 6 to 8 11,467 11,466 2
Trimer 0 8 17,201 17,198
Tetramer 0 8 to 10 22,932 22,932 0.1
Pentamer 0 7 to 9 28,665 28,666 0.5
Hexamer 0 8 to 10 34,398 34,399 0.1
Hexamer* 2 9 to 12 34,461 34,464 8
Hexamer 2 9 to 12 34,532 34,528 7
Hexamer 3 9 to 12 34,598 34,598 10
Hexamer 4 9 to 12 34,663 34,666 8
7-Mer 0 9 to 11 40,131 40,146 12
8-Mer 0 10 to 12 45,864 45,870  11
9-Mer 0 11 to 13 51,597 51,613  8
10-Mer 0 12, 13 57,330 57,344  3
11-Mer 0 13, 14 63,063 63,154  9
12-Mer 0 14 68,796 68,832
*This species arises from the assembly of five full-length insulin molecules
and a small proportion of truncated insulin (2%).
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4691 and 3969, while the (14) charge state of the 12-mer
is identified at m/z 4915. The low intensities of the signals
observed for the 9-mer (11 and 13) and the 12-mer
(14), and the intense peak assigned to the hexamer (9),
indicate that the major contribution to the peak at m/z 4300
is from the hexamer (8). Using this approach the complete
spectrum can be assigned (Fig. 3). It is interesting to note
that although the absolute intensities are sensitive to the
mass spectrometry conditions, the relative intensities of
different oligomers are reproducible and indicate that some
oligomers are present at higher concentrations than others.
Moreover, the distribution of the oligomers is almost iden-
tical whether or not buffer salts are present (data not
shown). For example, the charge states for the hexamer are
FIGURE 2 (A) Nano-ES mass
spectra of insulin at pH 3.3 over the
concentration range 2 M to 5 mM.
The charge states labeled M, D, and T
represent monomeric, dimeric, and
tetrameric insulin. The number in pa-
rentheses is the charge on the ion. The
peaks labeled * in the spectra ob-
tained from the 1 and 5 mM insulin
solutions are assigned to the 7
charge state of trimeric insulin. The
presence of this trimer has not been
reported in solution and is probably
an intermediate in the disassembly of
the weakly associated tetramer in the
gas phase. (B) Plot of the fraction of
the dimer observed by MS against the
logarithm of the insulin concentration
in the range 2–200 M at pH 3.3 and
22°C. The fraction of dimer was cal-
culated by summing the peaks as-
signed to the dimer and expressing
this value as a fraction of the total
signal intensity. Error bars were esti-
mated from the differences in the in-
tensities of the peak in replicate ex-
periments.
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always more intense that those for the pentamer and 7-mer
indicating that it is present at greater abundance. This sug-
gests that the hexamer has a higher intrinsic stability than
the pentamer and 7-mer.
In order to investigate the dynamic structure of the oli-
gomeric species we have used hydrogen exchange methods
to measure solvent exchange of labile hydrogens in oli-
gomers containing from two to six insulin molecules. The
nano-ES mass spectra of the trimer, tetramer, pentamer, and
hexamer of insulin before and after 1 h of exposure to D2O
are shown in Fig. 4 A. These show that the absolute increase
in mass observed in D2O solution is greater for higher
oligomers than for lower ones. Using this procedure the
hydrogen exchange kinetics of oligomers were monitored
over a time course from 10 min to 24 h and the results
plotted in Fig. 6 B. The results show that the hydrogen
exchange profiles are remarkably similar, a result consistent
with a linear increase in the number of sites protected as the
number of molecules in the oligomers increases. An alter-
native model is that increased size of the oligomers leads to
an exponential increase in protection. This is clearly not
observed under the conditions of this experiment. Calcula-
tion of the number of slowly exchanging sites per insulin
molecule after 360 min gives 20  2, 20  2, and 21  4
for the dimer, tetramer, and hexamer respectively. These
results indicate therefore that the molecular units in the
various oligomers have approximately equal protection
against exchange.
The possible role of these oligomers in fibril formation
was investigated by monitoring the concentrations of the
various species in solution at pH 2.0 and at a temperature of
70°C, conditions shown previously to promote fibril forma-
tion (Waugh et al., 1957; Brange et al., 1997a). Under these
conditions the solutions become increasingly difficult to
spray due to the presence of insoluble material in the nano-
flow needle tip. In order to measure the concentration of the
soluble bovine protein more accurately, human insulin was
added as an internal standard immediately before analysis.
This protein has the same ionization efficiency as the bovine
protein and does not form aggregates on the time scale and
conditions of the analysis (see Methods). The results show
that during the first 1 h of exposure to the fibril forming
conditions, the total area under the peak assigned to bovine
insulin does not change with respect to the internal standard
(Fig. 5, inset). At longer times a steady decrease in relative
intensity of the peaks assigned to bovine insulin was ob-
served. After 2.5 h the bovine protein could not be measured
relative to the peaks of the internal standard indicating that
the protein is in a highly aggregated structure. These data
show that there is a lag time for fibril formation; this was
determined to be 65 5 min under the conditions used here
for a 2 mM solution. Spectroscopic data for a solution with
FIGURE 3 Nano-ES mass spectrum from m/z 3700 to 5000 showing populations of higher oligomers present at pH 2.0, 2 mM, and 22°C. The number
of molecules in the oligomer is indicated and the charge state is shown in parentheses.
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a protein concentration of 8.8 mM at pH 1.55 at 80°C has
shown previously that fibrils began to form after approxi-
mately 50 min (Waugh et al., 1957). These data therefore
appear to be reasonably consistent despite the different
solution conditions. For solutions of 200 M and 20 M
protein at 70°C, lag times of 120  10 min and more than
6 h, respectively, were obtained using the mass spectromet-
ric approach.
FIGURE 4 Hydrogen exchange of oligomers
formed under aggregation conditions at pH 2.0, 2 mM
and room temperature. (A) Mass spectra of oligomers
formed in H2O and after 1 h in D2O. (B) Plot of the
number of protected sites remaining in (F), dimeric
(E), trimeric (), tetrameric (ƒ), pentameric (f), and
hexameric () insulin species as a function of time.
(C) Plot of the deviation of the hydrogen exchange
protection of the oligomers from that observed for
monomeric insulin. This value was calculated by di-
viding the total hydrogen exchange protection mea-
sured for each oligomer by the number of insulin
molecules in each species.
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The distribution of the various oligomers present in the
insulin solution, shown in Fig. 5, was monitored as a func-
tion of time during the aggregation process. Although this
process is extremely sensitive to the experimental condi-
tions, reproducible results could be obtained under carefully
controlled conditions. At the start of the time course the
spectrum recorded corresponds predominately to that of
monomeric and dimeric insulin although in the m/z range
between 3000 and 5000, it is possible to observe oligomeric
species similar to those shown in Fig. 3. The most intense
signals in this range are assigned as described above to a
tetramer (7), pentamer (7,8,9), hexamer (10,9,
8), and 7-mer (9, 10). These assignments enable the
relative proportions of the different species under aggrega-
tion conditions to be monitored with time. After 0.5 h at
70°C and pH 2.0 the relative intensities of all the oligomeric
species are seen to decrease markedly and the relative
proportion of hexamer has decreased more markedly than
that of the tetramer and pentamer. After 2 h the signals from
the higher oligomers are only just visible and the intensities
of the charge states from monomeric species are reduced
significantly. The dimer (5) peak is also significantly
reduced relative to those of the other oligomers and the
monomer (3). These observations could be a result of
changes in the total concentration of insulin in solution or
could reflect the reduced stability of the various oligomers
relative to the monomer at higher temperatures. In order to
address the latter possibility, the time-dependence experi-
ments were repeated at 60°C. At this temperature, where
aggregation does not take place at a detectable rate, the
FIGURE 5 Insert: Plot of the concentration of soluble insulin measured indirectly by the decrease in the charge states in the mass spectrum of insulin
relative to an internal standard against time (see Experimental Procedures). After 65 min the concentration decreases rapidly indicating rapid depletion of
soluble insulin as large aggregates form. Nano-ES mass spectra of insulin at 2 mM concentration after incubation at 70°C and pH 2.0. At t 	 0, before
heating, the mass spectrum shows predominantly monomeric and dimeric insulin with lower proportions of tetramer, pentamer and hexamer. After heating
for 30 min at 70°C the intensity of the hexamer and tetramer charge states are reduced relative to those of the pentamer. After 1.5 h the presence of higher
oligomers is significantly reduced and after 2 h monomeric insulin is the only species that can be observed in the mass spectrum. The spectrum above m/z
3000 has been multiplied by a factor of 40 to enable observation of the oligomers.
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relative proportions of the hexamer to the tetramer, pen-
tamer and 7-mer did not change over the 2 h time course of
the experiment. These results suggest therefore that the
decrease in the population of hexameric insulin relative to
other oligomers at 70°C is associated with the conversion of
soluble insulin to insoluble aggregates.
Characterization of fibrils by electron
microscopy, x-ray diffraction, and
FT-IR spectroscopy
The morphological changes involved in the formation of
insulin fibrils under the conditions of the mass spectromet-
ric experiments were investigated by electron microscopy
(EM). The insulin solution before heating did not show
appreciable quantities of aggregated material (Fig. 6 A).
After heating the pH 2.0 solutions containing 2 mM insulin
for 3 h at 70°C a network of fibrils is evident, apparently
consisting of single protofilaments with a high degree of
curvature, indicative of flexibility (Fig. 6 B). Continued
heating for 48 h shows the development of larger fibrils,
many containing at least two protofilaments and having a
well-defined helical twist of pitch 150 Å (Fig. 6 C). The
fibrils were also analyzed by x-ray fiber diffraction and the
resulting diffraction pattern showed a meridional reflection
at 4.83  0.01 Å with further reflections at 7.5  0.01 Å
and 11.3  0.01 Å (data not shown). These results are
consistent with similar data reported previously (Burke and
Rougvie, 1972a) and indicate that the fibrils have the char-
acteristic cross- structure common to all amyloid struc-
tures (Sunde et al., 1997).
Fourier transform infrared spectra in the region 1580–
1700 cm1 from soluble insulin and two preparations of the
aggregated material are shown in Fig. 7. This region con-
tains bands assigned to the amide I modes (essentially
C 	 O stretching vibrations of the amide group) that have
been used to characterize the conformation of proteins
(Glenner et al., 1974; Wei et al., 1991; Fabian et al., 1993;
Vecchio et al., 1996). In the spectrum of insulin in solution
at pH 2.0, in which all labile hydrogens were exchanged for
deuterium, the peak observed in the amide region has an
absorbance maximum at 1648 cm1. This arises from a
convolution of a number of absorption bands corresponding
to the various structural elements present in the native
solution conformation. In a previous study a peak with an
absorption maximum at 1650 cm1 was observed and as-
signed to a dominant -helical band (residues B9–B19)
(Krimm and Bandekar, 1986). The FT-IR spectra of the
samples incubated at 70°C are quite different from that of
soluble insulin recorded under the same solution conditions,
Fig. 7. The absorbance maximum in the amide region is at
1627 cm1 in the samples incubated for 3 h and 48 h. The
contribution to both spectra of the -helical absorption band
in the amide region at 1650 cm1 (Krimm and Bandekar,
1986) is much reduced relative to that of the soluble protein
sample. Moreover, this reduction is more marked where the
sample has undergone longer incubation. By contrast, the
contribution at 1627 cm1, thought to arise from parallel
-sheet (Wei et al., 1991), increases with the time of sample
incubation. These changes are consistent with a substantial
reduction in the -helical content of the protein structure on
conversion to amyloid fibrils, accompanied by a corre-
sponding increase in the amount of -sheet. The persistence
of a contribution to the peak at 1650 cm1, even after the
fibrils have been incubated for 48 h, indicates some -he-
lical and/or unstructured regions remain. However, the pre-
dominant structural characteristic of the fibril is its exten-
sive -sheet nature, a result in accord with data obtained
previously (Glenner et al., 1974). In a separate paper we
describe the time development of the FT-IR spectrum and
its relationship to morphological changes in the EM images
(Bouchard et al., submitted).
DISCUSSION
The nature of insulin species under different
solution conditions
In the presence of Zn2, hexamers of insulin containing two
to four Zn2 ions have been generated and maintained intact
in the gas phase. The insulin species detected in the gas
phase correspond closely to those anticipated from earlier
solution studies (Lord et al., 1973). The absence of signif-
icant intensity for signals from species such as the trimer
and pentamer indicates that the dimer, tetramer and hexamer
are the stable species under the solution conditions used
here. The effect of the concentration of the solutions from
which the species are generated has enabled measurements
of the stability constants of dimers, tetramers and hexamers
to be made. These results show that there is a good agree-
ment between the values of the stability constants obtained
from the proportions of species in the gas phase and the
values obtained from conventional solution methods (Lord
et al., 1973).
At high protein concentration the mass spectra are re-
markable in that they show the presence of oligomers con-
taining between 2 and 12 insulin molecules. The relative
intensities of the charge states corresponding to the tetramer
and the hexamer are higher than those of the pentamer or
7-mer and indicate that the probability of forming even
numbered species is higher than forming odd numbered
oligomers. The results presented here are consistent with
formation of a series of aggregates through association of
the dimer to give the tetramer and the hexamer in preference
to the pentamer and 7-mer. The relative proportions of the
monomeric and higher oligomeric species at 70°C, where
rapid fibril formation takes place, show little change in the
first hour of incubation. After this time the total solution
concentration falls rapidly. The population of all the higher
oligomers also decreases relative to the monomer although
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the intensities of the charge states of the hexamer are
reduced to a greater extent than those of the pentamer and
tetramer. Spectra recorded for insulin solutions at the same
protein pH and concentration but at 60°C, where rapid fibril
formation is not observed, did not show such changes in the
relative intensities. These results imply that the depletion of
the higher oligomers, in particular the hexamer, from the
solution at 70°C is connected with the formation of higher
aggregates and fibrils rather than to differences in thermal
stability of the different oligomers. One possibility is that
the hexamer is incorporated into a larger ordered structure
during the aggregation process.
Hydrogen exchange measurements reveal that an average
of 20  2 hydrogens are protected per insulin molecule in
each of oligomeric species examined. This number is sim-
ilar to that determined from NMR studies of insulin at pH
2.0 in 20% acetic acid, conditions which favor the mono-
meric form of the protein, where a total of 17 slowly
exchanging sites were observed (Hua and Weiss, 1991). The
origin of the slightly higher protection against hydrogen
FIGURE 6 Analysis of insulin fibrils by electron microscopy. Electron
micrographs of insulin samples were recorded for insulin during fibril
formation at 70°C (bar 	 2000 Å). Samples were collected before heating
(a) and after heating for 3 h (b), and 48 h (c). The micrographs show the
transition from young fibrils (b) to mature fibrils (c) in which the helical
twist of at least two protofilaments can be identified.
FIGURE 7 FT-IR spectra in the regions 1580–1700 cm1 of soluble
insulin and two preparations of fibrils incubated for 3 h and 48 h at 70°C.
The spectra show the transition from the essentially -helical protein
before heating to increasing amounts of -sheet structure during fibril
formation.
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exchange observed by MS over that recorded by NMR may
be attributed to changes in the intrinsic rate of exchange
arising from the different solution conditions (Bai et al.,
1993). The most important observation from this MS data
however is that the higher oligomers do not show increased
hydrogen exchange relative to the monomer whereas in
stable oligomeric species greater burial of surface area leads
to increased protection against exchange (Nettleton, 1998).
These results strongly suggest that the rate of interconver-
sion between oligomers is rapid relative to the time scale of
the hydrogen exchange measurements allowing solvent
molecules to exchange with labile sites in the intermolecular
interfaces.
Structural transitions during insulin
fibril formation
The results presented here allow us to examine the process
of insulin aggregation in the light of the mechanism of fibril
formation proposed for other amyloidogenic proteins (Harp-
er and Lansbury, 1997). There is an initial lag phase in the
formation of aggregates in which the concentration of sol-
uble insulin is maintained at a level close to its initial value,
following the transfer of insulin to conditions under which
fibrils eventually form. This phenomenon is seen in other
amyloidogenic systems, in particular A 1–40 and A
1–42 exhibit associated with Alzheimer’s disease (Jarrett et
al., 1993). The lag phase observed in this study is shorter at
higher concentrations, 65  5 min at 2 mM compared with
more than 6 h recorded for the 2 M insulin solution, a
finding similar to that observed with A peptides (Jarrett et
al., 1993). The absence of very large oligomers (species
above 12-mers) is significant given that the time-of-flight
instrumentation used for these experiments has recently
been shown to be capable of detecting signals from oli-
gomers having masses above 2 MDa (Rostom et al., 2000;
Tito et al., 2000). Based on sedimentation properties, high
molecular weight oligomers of A 1–40 have been pro-
posed with a molecular weight close to 4 MDa. The present
study implies that such species, if formed, are either above
2–3 MDa, or unstable at the high temperature employed to
form fibrils or not present at a significant concentration. The
oligomers observed for insulin are similar to those reported
for transthyretin where a ladder of oligomeric intermediates
with increasing molecular weight was observed (Lashuel et
al., 1998). The absence of very large intermediates and the
presence of a series of oligomers in solutions that ultimately
form fibrils may imply that for insulin the nucleation spe-
cies are relatively small.
The FT-IR spectra and the MS hydrogen exchange mea-
surements of the soluble protein before heating confirm that
under the solution conditions used here the various solution
species present in the lag phase contain extensive native-
like structure. The FT-IR spectra, however, show the emer-
gence of a large signal characteristic of -sheet structure
after the lag phase under conditions in which amyloid fibrils
form. The interstrand spacing of 4.83  0.01 Å measured
from x-ray diffraction patterns in the present study is in
close agreement with results from other amyloid fibrils
(Sunde et al., 1997) showing that the fibrils have the char-
acteristic cross--sheet structure found in all other amyloid
fibrils. Thus a major structural conversion must occur for
insulin on fibril formation, involving substantial unfolding
of the molecules to allow conversion of -helical to -sheet
structure. Destabilization of native state interactions and
exposure of the hydrophobic core has been proposed to be
involved in conversion of other normally soluble proteins to
fibrils. For example hydrogen exchange measurements have
shown enhanced conformational dynamics for variants of
human lysozyme (Booth et al., 1997; Canet et al., 1999) and
transthyretin (Nettleton et al., 1998; Kelly, 1998). The re-
sults from the present study of insulin show that substantial
loss of native state helical structure or loss of native-like
hydrogen exchange protection does not occur during the lag
period of fibril formation. Rather the loss of signal from
soluble protein, evident in the mass spectra during the lag
time, is consistent with the build up of insoluble aggregates
which FT-IR shows have extensive helical structure but
little -sheet character.
It appears therefore that there is a dynamic equilibrium
involving essentially native–like helical oligomers, present
initially during the lag phase, that associate during the latter
stages of this phase to form large aggregates. These aggre-
gates, not visible by mass spectrometry, may be related in
structure to models proposed for despentapeptide insulin, in
which the helical structure of the dimer was used as a model
for packing in the fibril (Brange et al., 1997b). The forma-
tion of fibrillar structure involves a transition from species
with substantial helical structure to those with extensive
-sheet. Although the present study does not provide evi-
dence directly for this step, it must involve a substantial
unfolding event in which labile intermolecular interactions
are replaced by persistent intramolecular hydrogen bonds
either by rearrangement of large aggregates or in a separate
nucleation event.
CONCLUSIONS
Despite the widespread use of insulin in the treatment of
type I diabetes the incidence of insulin fibril deposits at the
site of repeated injection has not been widely reported. This
is in contrast to fibril formation by a number of other
amyloidogenic proteins associated with clinical disorders.
For example 2-microglobulin is always a complication in
long term hemodialysis patients (Gejyo et al., 1985) and
transthyretin fibrils, associated with both senile and familial
forms of systemic amyloidosis, are widespread (Benson,
1989). This could well be due to the relative ease of fibril
formation of these proteins from conditions close to those
that can exist in vivo. By contrast a number of constraints
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exist in the insulin molecule that may give rise to the low
incidence of fibrils during the treatment of insulin depen-
dent diabetics. The fact that the native state of insulin is
remarkably stable to a wide range of pH and solution
conditions and the two short chains are constrained by
disulfide bonds suggests that unfolding events will not be
favored. This is in contrast to variants of transthyretin and
lysozyme where single amino acid mutations compromise
their stability leading to higher unfolding rates (Nettleton et
al., 1998; Canet et al., 1999) and to 2-microglobulin where
a single disulfide bond is present in the 12 kDa protein
(Gejyo et al., 1985). In addition, the neutral pH conditions
and the intrinsic stability of the Zn2 hexamer used in
pharmaceutical preparations of insulin, and the fact that the
hexamer does not readily dissociate until the local concen-
tration is below nanomolar, ensure that monomeric insulin
does not readily form fibrils. At nanomolar concentration
higher oligomers could not be detected by MS and would be
unlikely to form in vivo. Interestingly insulin fibril forma-
tion has been observed under hydrophobic solution condi-
tions both in vitro (Sluzky et al., 1991) and in vivo after
injection using plastic syringes (Dische et al., 1987). Such
conditions would be expected to promote unfolding of glob-
ular proteins leading to the dissociation of the insulin hex-
amer at higher local concentrations than in the absence of
hydrophobic surfaces, leading to the possibility of aggrega-
tion.
In addition to the significance of the present findings for
insulin itself, this study demonstrates the utility of mass
spectrometry in defining the solution states of a protein
system in oligomeric forms. This arises from the unique
ability of mass spectrometry to distinguish between chem-
ically identical species with different molecular masses.
While the precise quantity of such species is heavily depen-
dent upon the instrumental settings and conditions within
the mass spectrometer, the ability to control the dissociation
of macromolecular species enables the properties of indi-
vidual molecules to be defined (Rostom et al., 2000). The
proportion of aggregating species detected by mass spec-
trometry is relatively low in comparison with monomeric
species, with the intensity associated with the 12-mer gen-
erally being less than 0.1% of the signal for the monomer.
The fact that even at this intensity it is possible to detect and
probe the persistence of these species during the lag phase
of the aggregation process suggests that it might be possible
to investigate in more detail species associated with the
mechanism of aggregation. Moreover the ability to measure
hydrogen exchange properties from a wide range of solution
conditions, both individually and as part of a larger assem-
bly, suggests a unique approach to probing the dynamics of
association and dissociation processes in complex systems.
It seems likely therefore that mass spectrometry can be
applied not just to amyloidogenic proteins but to the forma-
tion of oligomeric species during aggregation and nucle-
ation processes more generally.
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